[ Price : $8.95]
FDA says it will act by 2/10/08 on an NDA for Adolor and GlaxoSmithKlines Entereg for managing postoperative ileus.[ Price : $8.95]
In todays batch of Warning Letters, FDA cites Spineology over an unapproved, misbranded, adulterated device, Optimesh.[ Price : $8.95]
Federal Register Notice: FDA withdraws approval of a Pennfield Oil NADA for bacitracin zinc Type A medicated article because it is...[ Price : $8.95]
Federal Register Final rule: FDA removes portions of the animal drug regulations that reflect approval of Pennfield Oils NADA for ...[ Price : $8.95]
CDER and ORA plan a new pilot program beginning next fiscal year to share more key information from review divisions to help direc...[ Price : $8.95]
Federal Register Notice: FDA corrects the time for oral presentations for the Preparation for ICH meetings in Yokohama, Japan sche...[ Price : $8.95]
FDA Office of Regulatory Affairs Division of Field Investigations director Michael Rogers tells an industry conference that the mo...[ Price : $8.95]
FDA says IDM Pharmas mifamurtide is not approvable for treating non-metastatic osteosarcoma.